Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology.
The world’s leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
American Society of Clinical Oncology
Loading...
The draft living guideline protocol for “Systemic Therapy and Biomarker Testing for HR-Positive, Non-HER2-Overexpressing Metastatic Breast Cancer" is open for comments. Please review & submit your comments by June 22 to help shape final recommendations.
Read & comment here: https://bit.ly/4vESw82
The draft guideline recommendations for "Prehabilitation for People with Cancer" are open for comments. Please review and submit your comments by June 15 to help shape final recommendations.
Read & comment: https://bit.ly/437XgGQ
The draft guideline recommendations for “Initial Treatment for Chronic Lymphocytic Leukemia" are open for comments. Please review and submit your comments by June 15 to help shape final recommendations.
Read & comment: https://bit.ly/437XgGQ
#CLL
ASCO Breakthrough has been gaining momentum since its inception in Thailand back in 2019. Hear from Dr. Tony S. K. Mok on how this vital conference has evolved and what's in store for #ASCOBT26 in Singapore.
Register today: https://bit.ly/4e1aydd
How do we integrate groundbreaking cancer innovations while ensuring they remain accessible? Join @oncologybg.bsky.social at #ASCOBT26 as he explores critical solutions for cancer care in the Asia-Pacific region.
Register today: https://bit.ly/4fnuObl
ICYMI at #ASCO26: GLP-1 RAs are associated with reduced metastatic progression of 4 different malignancies and improved OS in 7 tumor types, per the results of a real-world analysis of 10,000+ patients with cancer. #ASCODailyNews has more: https://bit.ly/43dQ3VK
There is a global surge in young-onset cancers, particularly within Asia Pacific. Dr. Kimmie Ng is looking forward to #ASCOBT26 to discuss why understanding these epidemiologic trends is more urgent than ever.
Join her and other global leaders in Singapore or online: https://bit.ly/3PLGsCE
Propel your career forward by submitting your research on topics ranging from Cost, Value & Policy to Tech. Innovation in Quality Care to #ASCOQLTY26 in Boston. Let’s advance quality cancer care together. ☕ Grab your Dunks & submit an abstract by June 16 at 11:59 PM (ET): https://bit.ly/49NsXsK
Don’t miss the chance to get your research funded! The @conquercancer.bsky.social YIA in Pediatric Brain Tumors is designed for investigators entering their first faculty role. International & U.S. applicants are welcome.
Learn more & apply by July 15, 2026: https://bit.ly/49MdrNS
#CancerResearch
ASCO Guideline Update: Stage IV NSCLC
New data confirms PD-(L)1 monotherapy (atezolizumab, pembrolizumab, cemiplimab) significantly improves PFS & OS vs. chemo for PD-L1 ≥ 50%. Five-year OS reached 31.9% in key trials.
Read the full guideline: https://bit.ly/4tSrhFB
#NSCLC #LungCancer
